April 16, 2021
Business News

Standigm Secures $44.5 M in Pre-IPO Funding Round


SEOUL, South Korea–()–Standigm Inc. (“Standigm”), a leading Korean Artificial Intelligence (AI) company for drug discovery, announces today that it has closed $44.5 million in a pre-IPO funding round co-led by SKS PE and Daishin Private Equity. The round was joined by new investors in banking and technology, including SKS PE, Daishin Private Equity, InterVest, KDB Bank, and Asset One, with follow-on investments from Standigm’s Series B investors Kakao Ventures, LB Investment, Atinum Investment, DSC Investment, and Wonik Investment Partners. Standigm’s second-largest shareholder, SK holdings, also participated through acquiring existing shares. The closing marks the last round of funding before Standigm…



Click here to view the original article.

Related Posts

You might also like ...

KBRA Assigns Preliminary Ratings to PRMI Securitization Trust 2021-1 (PRMI 2021-1)
AON Splash Image
Census Bureau to Host Educational Webinar to Provide Insights on Upcoming Quality Metrics Release
INTZ CLASS ACTION NOTICE: Glancy Prongay & Murray LLP Files Securities Fraud Lawsuit Against Intrusion Inc.